Checkpoint Responses in Cancer Therapy

Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called "checkpoints" – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now prom...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Dai, Wei (Editor)
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press, 2008.
Series:Cancer Drug Discovery and Development•
Subjects:
Online Access:Full Text via HEAL-Link
Table of Contents:
  • RB-Pathway
  • Targeting the p53/MDM2 Pathway for Cancer Therapy
  • DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer
  • Targeting ATM/ATR in the DNA Damage Checkpoint
  • Compounds that Abrogate the G2 Checkpoint
  • CDK Inhibitors as Anticancer Agents
  • CHFR as a Potential Anticancer Target
  • Antimicrotubule Agents
  • Kinesin Motor Inhibitors as Effective Anticancer Drugs
  • Targeting the Spindle Checkpoint in Cancer Chemotherapy
  • Antiproliferation Inhibitors Targeting Aurora Kinases
  • Plks as Novel Targets for Cancer Drug Design
  • Do Histone Deacetylase Inhibitors Target Cell Cycle Checkpoints that Monitor Heterochromatin Structure?.